Who invested in Sigilon Therapeutics?
Sigilon Therapeutics's investors include BlackRock, Eli Lilly, CPP Investments and Flagship Pioneering.
Who invested in Sigilon Therapeutics
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$145Mraised across 1 round since 2020, from 1 source
- Latest round
- Round, $145MDec 2020
- Investors
- 4
The rounds
- Dec 2020
Everyone who backed them
CPP InvestmentsGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Sigilon Therapeutics
How much has Sigilon Therapeutics raised?
Sigilon Therapeutics has raised $145M across 1 round since 2020.
When did Sigilon Therapeutics last raise?
Sigilon Therapeutics's most recent round was an Undisclosed round of $145M in Dec 2020.
What was Sigilon Therapeutics's biggest round?
Its most recent round, $145M in Dec 2020, is also its largest on record.
Who backed Sigilon Therapeutics first?
Sigilon Therapeutics's first round on record, in Dec 2020, was backed by BlackRock, Eli Lilly and CPP Investments and 1 others.
What stage is Sigilon Therapeutics at?
Sigilon Therapeutics's latest named round is an Undisclosed round, in Dec 2020.
Companies like Sigilon Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.